Ask me later
Ask me later
How likely are you to recommend Redeye to a friend or colleague?
1
2
3
4
5
6
7
8
9
10
Not likely
Very likely
Not likely
1
2
3
4
5
6
7
8
9
10
Very likely
Thanks again for rating us!
Evaxion Biotech: Interview about the new ObsERV platform with CEO Per Norlén(video)
Research Interview
2023-03-24
13:06
Redeye interviews CEO Per Norlén about the new ObsERV platform which identifies endogenous retroviruses as targets for personalized cancer treatment.
RR
Richard Ramanius
Disclosures and disclaimers